160 related articles for article (PubMed ID: 36882191)
1. Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.
Fu C; Pang H; Zhou S; Zhu J
Pharm Stat; 2023; 22(4):619-632. PubMed ID: 36882191
[TBL] [Abstract][Full Text] [Related]
2. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
Wang X; Suttner L; Jemielita T; Li X
J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
[TBL] [Abstract][Full Text] [Related]
3. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Harun N; Liu C; Kim MO
Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
[TBL] [Abstract][Full Text] [Related]
4. Bayesian adaptive design for covariate-adaptive historical control information borrowing.
Jin H; Kim MO; Scheffler A; Jiang F
Stat Med; 2023 Dec; 42(29):5338-5352. PubMed ID: 37750361
[TBL] [Abstract][Full Text] [Related]
5. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
Sawamoto R; Oba K; Matsuyama Y
Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
[TBL] [Abstract][Full Text] [Related]
6. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
[TBL] [Abstract][Full Text] [Related]
7. Bayesian Divide-and-Conquer Propensity Score Based Approaches for Leveraging Real World Data in Single Arm Clinical Trials.
Baron E; Zhu J; Tang RS; Chen MH
J Biopharm Stat; 2022 Jan; 32(1):75-89. PubMed ID: 35094643
[TBL] [Abstract][Full Text] [Related]
8. Utility of propensity score-based Bayesian borrowing of external adult data in pediatric trials: A pragmatic evaluation through a case study in acute lymphoblastic leukemia (ALL).
Majumdar A; Rothwell R; Reaman G; Ahlberg C; Roy P
J Biopharm Stat; 2023 Nov; 33(6):737-751. PubMed ID: 36600441
[TBL] [Abstract][Full Text] [Related]
9. A frequentist approach to dynamic borrowing.
Li R; Lin R; Huang J; Tian L; Zhu J
Biom J; 2023 Oct; 65(7):e2100406. PubMed ID: 37189217
[TBL] [Abstract][Full Text] [Related]
10. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
Liu M; Bunn V; Hupf B; Lin J; Lin J
Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
[TBL] [Abstract][Full Text] [Related]
11. Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.
Su L; Chen X; Zhang J; Yan F
JCO Precis Oncol; 2022 Mar; 6():e2100394. PubMed ID: 35263169
[TBL] [Abstract][Full Text] [Related]
12. Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing.
Spanakis E; Kron M; Bereswill M; Mukhopadhyay S
J Biopharm Stat; 2023 Nov; 33(6):752-769. PubMed ID: 36507718
[TBL] [Abstract][Full Text] [Related]
13. Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach.
Yang S; Li F; Thomas LE; Li F
Clin Trials; 2021 Oct; 18(5):570-581. PubMed ID: 34269087
[TBL] [Abstract][Full Text] [Related]
14. Incorporating propensity scores for evidence synthesis under bayesian framework: review and recommendations for clinical studies.
Lin J; Lin J
J Biopharm Stat; 2022 Jan; 32(1):53-74. PubMed ID: 33998364
[TBL] [Abstract][Full Text] [Related]
15. Conditional borrowing external data to establish a hybrid control arm in randomized clinical trials.
Li H; Tiwari R; Li QH
J Biopharm Stat; 2022 Nov; 32(6):954-968. PubMed ID: 35067183
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Evaluating hybrid controls methodology in early-phase oncology trials: A simulation study based on the MORPHEUS-UC trial.
Wang G; Poulin-Costello M; Pang H; Zhu J; Helms HJ; Reyes-Rivera I; Platt RW; Pang M; Koukounari A
Pharm Stat; 2024; 23(1):31-45. PubMed ID: 37743566
[TBL] [Abstract][Full Text] [Related]
18. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
Quan H; Zhang B; Lan Y; Luo X; Chen X
Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
[TBL] [Abstract][Full Text] [Related]
19. Bayesian Approach for Addressing Differential Covariate Measurement Error in Propensity Score Methods.
Hong H; Rudolph KE; Stuart EA
Psychometrika; 2017 Dec; 82(4):1078-1096. PubMed ID: 27738956
[TBL] [Abstract][Full Text] [Related]
20. Bayesian methods for the analysis of early-phase oncology basket trials with information borrowing across cancer types.
Jin J; Riviere MK; Luo X; Dong Y
Stat Med; 2020 Nov; 39(25):3459-3475. PubMed ID: 32717103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]